BACKGROUND: In patients with sinoatrial nodal (SAN) dysfunction, atrial pauses lasting several seconds may follow rapid atrial pacing or paroxysmal tachycardia (tachy-brady arrhythmias). Clinical studies suggest that adenosine may play an important role in SAN dysfunction, but the mechanism remains unclear. OBJECTIVE: To define the mechanism of SAN dysfunction induced by the combination of adenosine and tachycardia. METHODS: We studied the mechanism of SAN dysfunction produced by a combination of adenosine and rapid atrial pacing in isolated coronary-perfused canine atrial preparations by using high-resolution optical mapping (n = 9). Sinus cycle length and sinoatrial conduction time (SACT) were measured during adenosine (1-100 μM) and DPCPX (1 μM; A1 receptor antagonist; n = 7) perfusion. Sinoatrial node recovery time was measured after 1 minute of "slow" pacing (3.3 Hz) or tachypacing (7-9 Hz). RESULTS: Adenosine significantly increased sinus cycle length (477 ± 62 ms vs 778 ± 114 ms; P<.01) and SACT during sinus rhythm (41 ± 11 ms vs 86 ± 16 ms; P<.01) in a dose-dependent manner. Adenosine dramatically affected SACT of the first SAN beat after tachypacing (41 ± 5 ms vs 221 ± 98 ms; P<.01). Moreover, at high concentrations of adenosine (10-100 μM), termination of tachypacing or atrial flutter/fibrillation produced atrial pauses of 4.2 ± 3.4 seconds (n = 5) owing to conduction block between the SAN and the atria, despite a stable SAN intrinsic rate. Conduction block was preferentially related to depressed excitability in SAN conduction pathways. Adenosine-induced changes were reversible on washout or DPCPX treatment. CONCLUSIONS: These data directly demonstrate that adenosine contributes to post-tachycardia atrial pauses through SAN exit block rather than slowed pacemaker automaticity. Thus, these data suggest an important modulatory role of adenosine in tachy-brady syndrome.
BACKGROUND: In patients with sinoatrial nodal (SAN) dysfunction, atrial pauses lasting several seconds may follow rapid atrial pacing or paroxysmal tachycardia (tachy-brady arrhythmias). Clinical studies suggest that adenosine may play an important role in SAN dysfunction, but the mechanism remains unclear. OBJECTIVE: To define the mechanism of SAN dysfunction induced by the combination of adenosine and tachycardia. METHODS: We studied the mechanism of SAN dysfunction produced by a combination of adenosine and rapid atrial pacing in isolated coronary-perfused canine atrial preparations by using high-resolution optical mapping (n = 9). Sinus cycle length and sinoatrial conduction time (SACT) were measured during adenosine (1-100 μM) and DPCPX (1 μM; A1 receptor antagonist; n = 7) perfusion. Sinoatrial node recovery time was measured after 1 minute of "slow" pacing (3.3 Hz) or tachypacing (7-9 Hz). RESULTS:Adenosine significantly increased sinus cycle length (477 ± 62 ms vs 778 ± 114 ms; P<.01) and SACT during sinus rhythm (41 ± 11 ms vs 86 ± 16 ms; P<.01) in a dose-dependent manner. Adenosine dramatically affected SACT of the first SAN beat after tachypacing (41 ± 5 ms vs 221 ± 98 ms; P<.01). Moreover, at high concentrations of adenosine (10-100 μM), termination of tachypacing or atrial flutter/fibrillation produced atrial pauses of 4.2 ± 3.4 seconds (n = 5) owing to conduction block between the SAN and the atria, despite a stable SAN intrinsic rate. Conduction block was preferentially related to depressed excitability in SAN conduction pathways. Adenosine-induced changes were reversible on washout or DPCPX treatment. CONCLUSIONS: These data directly demonstrate that adenosine contributes to post-tachycardia atrial pauses through SAN exit block rather than slowed pacemaker automaticity. Thus, these data suggest an important modulatory role of adenosine in tachy-brady syndrome.
Authors: Vadim V Fedorov; Roger Chang; Alexey V Glukhov; Geran Kostecki; Deborah Janks; Richard B Schuessler; Igor R Efimov Journal: Circulation Date: 2010-08-09 Impact factor: 29.690
Authors: Ning Li; Brian J Hansen; Thomas A Csepe; Jichao Zhao; Anthony J Ignozzi; Lidiya V Sul; Stanislav O Zakharkin; Anuradha Kalyanasundaram; Jonathan P Davis; Brandon J Biesiadecki; Ahmet Kilic; Paul M L Janssen; Peter J Mohler; Raul Weiss; John D Hummel; Vadim V Fedorov Journal: Sci Transl Med Date: 2017-07-26 Impact factor: 17.956
Authors: Angelo G Torrente; Rui Zhang; Audrey Zaini; Jorge F Giani; Jeanney Kang; Scott T Lamp; Kenneth D Philipson; Joshua I Goldhaber Journal: Proc Natl Acad Sci U S A Date: 2015-07-20 Impact factor: 11.205
Authors: Alexey V Glukhov; Anuradha Kalyanasundaram; Qing Lou; Lori T Hage; Brian J Hansen; Andriy E Belevych; Peter J Mohler; Björn C Knollmann; Muthu Periasamy; Sandor Györke; Vadim V Fedorov Journal: Eur Heart J Date: 2013-11-11 Impact factor: 29.983
Authors: Thomas A Csepe; Jichao Zhao; Brian J Hansen; Ning Li; Lidiya V Sul; Praise Lim; Yufeng Wang; Orlando P Simonetti; Ahmet Kilic; Peter J Mohler; Paul M L Janssen; Vadim V Fedorov Journal: Prog Biophys Mol Biol Date: 2015-12-30 Impact factor: 3.667
Authors: Alexey V Glukhov; Lori T Hage; Brian J Hansen; Adriana Pedraza-Toscano; Pedro Vargas-Pinto; Robert L Hamlin; Raul Weiss; Cynthia A Carnes; George E Billman; Vadim V Fedorov Journal: Circ Arrhythm Electrophysiol Date: 2013-08-19
Authors: Victor P Long; Ingrid M Bonilla; Stephen Baine; Patric Glynn; Sanjay Kumar; Karsten Schober; Kent Mowrey; Raul Weiss; Nam Y Lee; Peter J Mohler; Sandor Györke; Thomas J Hund; Vadim V Fedorov; Cynthia A Carnes Journal: Life Sci Date: 2019-11-18 Impact factor: 5.037
Authors: Qing Lou; Brian J Hansen; Olga Fedorenko; Thomas A Csepe; Anuradha Kalyanasundaram; Ning Li; Lori T Hage; Alexey V Glukhov; George E Billman; Raul Weiss; Peter J Mohler; Sándor Györke; Brandon J Biesiadecki; Cynthia A Carnes; Vadim V Fedorov Journal: Circulation Date: 2014-05-16 Impact factor: 29.690
Authors: Thomas A Csepe; Anuradha Kalyanasundaram; Brian J Hansen; Jichao Zhao; Vadim V Fedorov Journal: Front Physiol Date: 2015-02-12 Impact factor: 4.566
Authors: Pietro Mesirca; Vadim V Fedorov; Thomas J Hund; Angelo G Torrente; Isabelle Bidaud; Peter J Mohler; Matteo E Mangoni Journal: Annu Rev Pharmacol Toxicol Date: 2020-10-05 Impact factor: 13.820